Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 12;18(3):1244-1247.
doi: 10.1016/j.radcr.2022.12.058. eCollection 2023 Mar.

Oncocytic carcinoma of parotid gland

Affiliations
Case Reports

Oncocytic carcinoma of parotid gland

Ho Xuan Tuan et al. Radiol Case Rep. .

Abstract

Of 0.5% all epithelial salivary gland malignancies are oncocytic cancers, a rare kind of parotid gland cancer. Clinical signs include discomfort and swelling in the cheek region, and the facial nerve is occasionally affected, leading to unilateral facial paralysis. Currently, surgery is the preferred choice of therapy. In this paper, we aimed to provide a case of an 84-year-old male who had an oncocytic carcinoma in the right parotid gland. A heterogeneous, poorly defined hypoechogenic lesion with minor vascular proliferation was seen by Doppler ultrasonography in the superficial lobe of the right parotid gland. On a computed tomography (CT) with contrast agent, an ill-defined mass filling the right parotid gland was evident. With the aid of the CT results of a heterogeneous enhancing mass with poorly defined boundary and expansion of adjacent lymph nodes, it may be able to differentiate between malignant lesions and benign parotid tumors.

Keywords: Computed tomography; Oncocytic carcinoma; Parotid gland; Ultrasound.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
A hypoechoic mass with an ill-defined border was seen on color-Doppler mode ultrasonography in the right parotid gland (arrow).
Fig 2
Fig. 2
Axial CT image without contrast agent (A), axial (B), and coronal (C) CT images with contrast agent showed a heterogeneous enhancing mass (arrow) with an ill-defined boundary in the right parotid gland's superficial and deep lobes.

References

    1. Sando Z, Fokouo JV, Mebada AO, Djomou F, ND A, Oyono JL. Epidemiological and histopathological patterns of salivary gland tumors in Cameroon. Pan Afr Med J. 2016;23:66. doi: 10.11604/pamj.2016.23.66.5105. Epub 2016/05/25. PubMed PMID: 27217890; PubMed Central PMCID: PMCPMC4862794. - DOI - PMC - PubMed
    1. Dimitrijevic MV, Boricic IV, Tomanović NR, Dimitrijevic AM, Bjelogrlić GM, Krstić AM, et al. Clinicopathological analysis of 907 major and minor salivary gland tumors. J Craniofac Surg. 2022;33(5):e507–e5e9. doi: 10.1097/scs.0000000000008482. PubMed PMID: 00001665-202207000-00106. - DOI - PubMed
    1. Lee TH, Lin YS, Lee WY, Wu TC, Chang SL. Malignant transformation of a benign oncocytoma of the submandibular gland: a case report. Kaohsiung J Med Sci. 2010;26(6):327–332. doi: 10.1016/S1607-551X(10)70047-4. Epub 2010/06/12. PubMed PMID: 20538238. - DOI - PMC - PubMed
    1. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006;85(2):74. Epub 2006/04/04. PubMed PMID: 16579185. - PubMed
    1. Kontaxis A, Zanarotti U, Kainz J, Beham A. Diffuse hyperplastic oncocytosis of the parotid gland. Laryngorhinootologie. 2004;83(3):185–188. doi: 10.1055/s-2004-814267. Epub 2004/03/26. PubMed PMID: 15042484. - DOI - PubMed

Publication types

LinkOut - more resources